Bionano Genomics (BNGO) EGM 2025 summary

Opening remarks and agenda

• Meeting called to order by the Chair, with introductions of key legal and executive attendees.

• Meeting held virtually, with stockholders attending via web portal.

• Agenda set to follow the Notice of Special Meeting and Proxy Statement.

Specific resolutions to be voted on

• Approval of issuance of up to 19,762,226 shares of common stock upon exercise of Series C and D warrants, in compliance with Nasdaq Listing Rule 5635(b).

• Approval of alternate amendments to the Certificate of Incorporation to effect a reverse stock split at a ratio between 1-for-25 and 1-for-75, at the Board's discretion.

Corporate governance

• Inspector of Election appointed and sworn in to oversee voting and ensure impartiality.

• Quorum established with approximately 41% of outstanding shares represented.

• Voting conducted by proxy and online ballot, with each share entitled to one vote.